France inflation (year-on-year): health products
France inflation (year-on-year): health products stood at -2.3% in Sep 2026, according to INSEE – Institut national de la statistique et des études économiques (BDM). It is one of the indicators in the Consumer price index table (Value · Monthly), with a complete series running from Jan 1996 to Sep 2026. The complete series with an interactive chart, free to download.
This indicator in the Consumer price index table
| Indicator | 09-2026 | 08-2026 | 07-2026 | 06-2026 | 05-2026 | 04-2026 | 03-2026 | 02-2026 | 01-2026 | 12-2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-on-year change | |||||||||||
| All households - Health products | -2.3 | -2.3 | -2.2 | -3.5 | -3.4 | -3.2 | -2.7 | -1.9 | -1.6 | -1.8 | |
| All households - Manufactured products excluding clothing,shoes and health products | 0.4 | 0.1 | -0.1 | -0.3 | -0.1 | -0.1 | -0.2 | -0.1 | -0.9 | -0.2 |
Understanding france inflation (year-on-year): health products
Pharmaceutical preparations, therapeutic appliances, medical equipment, and optical products purchased directly by households define the exact boundaries of this health merchandise metric. Unlike clinical doctor consultations or hospital treatment fees, this tracking captures tangible medical goods acquired through pharmacies, specialized suppliers, and optical stores. The compilation includes prescription drugs, over-the-counter remedies, corrective lenses, and first-aid supplies, while entirely excluding professional medical services and institutional healthcare administration costs.
Evaluating these figures requires close attention to government reimbursement schedules, social security regulatory changes, and statutory price caps that frequently dictate retail pharmacy pricing. The twelve-month percentage change provides a stable analytical view by removing minor administrative adjustments and occasional policy implementation dates. Early statistical estimates are remarkably stable because pharmaceutical pricing is heavily regulated and published through official tariff lists, minimizing unexpected revisions. When analyzing this series alongside broader retail indices, observers must recognize that public health subsidies can artificially suppress price movements compared to unregulated consumer goods.
Frequently asked questions
- What specific health-related goods are captured in this product group?
- It measures prescription drugs, over-the-counter remedies, medical devices, and optical products.
- Why are clinical consultations excluded from this particular health index?
- Clinical visits and hospital procedures are classified separately under health services rather than tangible goods.
- How do government regulations influence pharmaceutical price tracking?
- Official reimbursement rates and statutory price caps often restrict normal retail price adjustments in this sector.